Literature DB >> 29271667

SOX7 Suppresses Wnt Signaling by Disrupting β-Catenin/BCL9 Interaction.

Rong Fan1, HaiYan He2, Wang Yao1, YanFeng Zhu1, XunJie Zhou1, MingTai Gui1, Jing Lu2, Hao Xi2, ZhongLong Deng1, Min Fan1.   

Abstract

The Wnt signaling is involved in angiogenesis and tumor development. β-catenin is the core component of the Wnt pathway, which mediates oncogenic transcription and regulated by a series of proteins. Sex-determining region Y-box 7 (SOX7) is a member of high-mobility-group transcription factor family, which inhibits oncogenic Wnt signaling in lots of tumor cells with unknown mechanism. By coimmunoprecipitation (co-IP) and super Topflash reporter assay, SOX7 can bind β-catenin and inhibit β-catenin/T cell factor (TCF)-mediated transcription. Meanwhile, B cell lymphoma 9 (BCL9) drives Wnt signaling path through direct binding-mediated β-catenin. Finally, we found that SOX7 inhibits oncogenic β-catenin-mediated transcription by disrupting the β-catenin/BCL9 interaction. Mechanistically, SOX7 compete with BCL9 to bind β-catenin. Our results show SOX7 inhibited Wnt signaling as suppressor and could be an important target for anticancer therapy.

Entities:  

Keywords:  BCL9; SOX7; Wnt signaling; cancer; β-catenin

Mesh:

Substances:

Year:  2017        PMID: 29271667     DOI: 10.1089/dna.2017.3866

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  7 in total

1.  Inhibition of β-catenin/B cell lymphoma 9 protein-protein interaction using α-helix-mimicking sulfono-γ-AApeptide inhibitors.

Authors:  Peng Sang; Min Zhang; Yan Shi; Chunpu Li; Sami Abdulkadir; Qi Li; Haitao Ji; Jianfeng Cai
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-14       Impact factor: 11.205

2.  Bioinformatics analysis of SOXF family genes reveals potential regulatory mechanism and diagnostic value in cancers.

Authors:  Dan Wu; Chuan Jiang; Jing-Jing Zheng; De-Sheng Luo; Ji Ma; Hai-Feng Que; Chao Li; Chao Ma; Hui-Yong Wang; Wei Wang; Hong-Tao Xu
Journal:  Ann Transl Med       Date:  2022-06

3.  BCL9 provides multi-cellular communication properties in colorectal cancer by interacting with paraspeckle proteins.

Authors:  Meng Jiang; Yue Kang; Tomasz Sewastianik; Jiao Wang; Helen Tanton; Keith Alder; Peter Dennis; Yu Xin; Zhongqiu Wang; Ruiyang Liu; Mengyun Zhang; Ying Huang; Massimo Loda; Amitabh Srivastava; Runsheng Chen; Ming Liu; Ruben D Carrasco
Journal:  Nat Commun       Date:  2020-01-07       Impact factor: 14.919

4.  miR-146a Inhibited Pancreatic Cancer Cell Proliferation by Targeting SOX7.

Authors:  Chouman Sulidankazha; Wei Han; Tieying He; Hai Lin; Kun Cheng; Xiaohan Nie; Qilong Chen
Journal:  J Healthc Eng       Date:  2022-02-16       Impact factor: 2.682

5.  SOX7 Target Genes and Their Contribution to Its Tumor Suppressive Function.

Authors:  Yumeng Zhang; Daniel B Stovall; Meimei Wan; Qiang Zhang; Jeff W Chou; Dangdang Li; Guangchao Sui
Journal:  Int J Mol Sci       Date:  2018-05-14       Impact factor: 5.923

Review 6.  microRNA: The Impact on Cancer Stemness and Therapeutic Resistance.

Authors:  Xueqiao Jiao; Xianling Qian; Longyuan Wu; Bo Li; Yi Wang; Xinyu Kong; Lixia Xiong
Journal:  Cells       Date:  2019-12-18       Impact factor: 6.600

7.  Low BCL9 expression inhibited ovarian epithelial malignant tumor progression by decreasing proliferation, migration, and increasing apoptosis to cancer cells.

Authors:  Jing Wang; Mingjun Zheng; Liancheng Zhu; Lu Deng; Xiao Li; Linging Gao; Caixia Wang; Huimin Wang; Juanjuan Liu; Bei Lin
Journal:  Cancer Cell Int       Date:  2019-12-06       Impact factor: 5.722

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.